Medline Inc.

MDLN | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.12

+$0.12 (+0.37%)

At close: Oct 30, 2026, 4:00 PM ET

$32.30

+$0.18 (+0.56%)

Pre-market: Nov 2, 2026, 7:27 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $28.18B

Enterprise Value $38.14B

Beta -0.41

Average Volume 8.02M

Shares Outstanding (Diluted) 861M

Shares Change YoY 9.39%

Institutional Ownership 91.88%

Exchange NASDAQ

ISIN US58507V1070

Price Performance

Price Change 1M -7.4%

Price Change 3M -18.2%

Price Change 6M -28.2%

Price Change YTD -23.5%

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 1.5%

1Y CAGR (ann.) N/A

5Y CAGR (ann.) N/A

All-Time CAGR -24.5%

Valuation

PE Ratio 37.35

Forward PE 22.39

PEG Ratio -1.24

Forward PEG 1.57

PS Ratio 0.94

Forward PS 0.80

PB Ratio 2.44

P/FCF Ratio 13.91

P/Adj. FCF Ratio 14.11

P/OCF Ratio 13.84

EV/Sales 1.27

EV/EBIT 23.71

EV/EBITDA 14.97

EV/FCF 18.83

Earnings Yield 2.7%

FCF Yield 7.2%

Adj. FCF Yield 7.1%

Financial Health

Net Debt $9.9B

Total Debt $12.64B

Cash & Short-Term Investments $2.68B

Total Assets $39.35B

Current Ratio 4.33

Quick Ratio 2.61

Debt / Equity Ratio 1.09

Debt / EBITDA 4.96

Debt / FCF 6.24

OCF / Debt 0.16

Interest Coverage 2.50

Altman Z-Score 2.01

Piotroski F-Score 7

Margins & Profitability

Gross Profit Margin 25.0%

Operating Profit Margin 6.1%

EBITDA Margin 8.8%

Net Profit Margin 2.3%

FCF Margin 6.8%

Adj. FCF Margin 6.7%

SBC / Revenue 0.1%

SBC Impact (per share) -1.4%

Returns

Return on Assets 1.8%

Return on Equity 5.5%

Return on Invested Capital 4.0%

Return on Capital Employed 5.0%

Return on Tangible Assets 3.9%

Historical Growth (CAGR)

Revenue CAGR 3Y 9.8%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 52.1%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -3.8%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 18

EPS Growth Next 3Y 32.9%

Revenue Growth Next 3Y 9.3%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) $0.34

EPS Growth Est (next Q) 10.7%

Revenue Est (next Q) $7.72B

Revenue Growth Est (next Q) 8.5%

Fair Value Estimates

Graham Number $20.75

Graham Upside -35.4%

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $44.20

Price Target Upside 37.6%

Cash Flow

Operating Cash Flow $1.99B

Free Cash Flow $2.03B

Adj. Free Cash Flow $2B

FCF Per Share $2.36

OCF Per Share $2.32

OCF/S Ratio 6.7%

Income Statement

Revenue $29.94B

Gross Profit $7.49B

Operating Income $1.82B

EBITDA $2.55B

Net Income $691M

EPS (Diluted) $0.86

Revenue / Employee $665.31K

Profit / Employee $15.36K

Employees 45,000